Ned Wydysh, Ph.D

Ned Wydysh, Ph.D

Ned Wydysh, Ph.D

Vice President, Health Advances

Ned joined Health Advances in 2012 and is a leader in the biopharma practice. He has extensive experience supporting the advancement of novel therapeutics, including efforts focused on development and commercialization strategy, opportunity assessment, portfolio prioritization, competitive market evaluation, and forecasting.

He is a co-leader of the Cell and Gene Therapy practice and a leader of the internal Oncology Business Development Committee. His work spans therapeutic areas, with specific areas of focus including solid tumor oncology, hematologic malignancies, orphan/genetic diseases, CNS, and autoimmune diseases.

Work experience

Prior to joining Health Advances, Ned was an analyst in the Autoimmune and Inflammatory disease group at Decision Resources, where he was responsible for developing market forecasts and evaluating the competitive landscapes in indications including asthma, COPD, systemic lupus erythematosus, benign prostatic hyperplasia, and rheumatoid arthritis.

Education

Ned received his BA in Chemistry from Williams College and his PhD in Chemistry from Johns Hopkins University.

Connect With Me

We are always available for a conversation.

*  

We are always available for a conversation.

Submitting...

Communication Preference

Communication Preference